首页> 外文会议>International Mass Spectrometry Conference >LC-MS/MS METHOD FOR ANALYSIS OF THERAPEUTIC PEPTIDE AXON PEPTIDE 108 IN AADVAC1 DRUG PRODUCT
【24h】

LC-MS/MS METHOD FOR ANALYSIS OF THERAPEUTIC PEPTIDE AXON PEPTIDE 108 IN AADVAC1 DRUG PRODUCT

机译:用于分析AADCAC1药品的治疗肽轴突108的LC-MS / MS方法

获取原文

摘要

Alzheimer's disease (AD) is a neurodegenerative disorder responsible for more than 70% of all dementia cases. This disease is characterized neurologically by progressive loss of memory, behavior, language, and visuo-spatial skills impairments. AD has become the focus of one of the most intensive investigation in the medicinal field because of worldwide universal phenomenon - population aging and considerable economic impact. Novel therapeutic strategies based on biologicals are currently under investigation recently. One of the innovative AD therapeutic in clinical trials is AADvac1 - immunotherapy designed to elicit an immune response against pathologically modified forms of tau protein, developed by Axon Neuroscience [1,2]. Herein, we present combination of simple acidic chemical cleavage (sample preparation step) with effective and very fast LC-MS/MS method for quantification of immunogen Axon Peptide 108 in AADvac1.
机译:阿尔茨海默病(AD)是一种神经退行性疾病,负责所有痴呆病例的70%以上。这种疾病通过逐步丧失记忆,行为,语言和潜伏空间技能损伤来表征了神经根学上的。由于全球普遍现象 - 人口老龄化和相当大的经济影响,广告已成为药物领域最集中化的焦点。目前正在调查基于生物的新型治疗策略。临床试验中的创新性AD治疗之一是AAGCAC1 - 免疫疗法,旨在引发由Axon神经科学的轴突发育的病理修饰形式的免疫反应[1,2]。在此,我们呈现简单的酸性化学切割(样品制备步骤)的组合具有有效且非常快的LC-MS / MS / MS方法,用于定量AAGHAC1中的免疫原轴突108。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号